Neuro-pharmacological evaluation of structurally novel 5-hydroxytryptamine type 3 receptor antagonist, N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n) for its anxiolytic potential
| dc.contributor.author | Mahesh, R. | |
| dc.date.accessioned | 2023-11-24T07:06:13Z | |
| dc.date.available | 2023-11-24T07:06:13Z | |
| dc.date.issued | 2013 | |
| dc.description.abstract | The present study was designed to investigate the anxiolytic activity of "N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n)," a novel 5-hydroxytryptamine Type 3 (5-HT 3) receptor antagonist in experimental mouse models of anxiety. | en_US |
| dc.identifier.uri | https://journals.lww.com/ijnp/Fulltext/2013/03040/Neuro_pharmacological_evaluation_of_structurally.10.aspx | |
| dc.identifier.uri | http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13253 | |
| dc.language.iso | en | en_US |
| dc.publisher | Medknow | en_US |
| dc.subject | Pharmacy | en_US |
| dc.subject | Neuro-pharmacological | en_US |
| dc.subject | Antagonists | en_US |
| dc.title | Neuro-pharmacological evaluation of structurally novel 5-hydroxytryptamine type 3 receptor antagonist, N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n) for its anxiolytic potential | en_US |
| dc.type | Article | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: